Jennifer H. Law
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Identifying Patients With High-Risk Stage I NSCLC Using a Tumor-Informed Plasma ctDNA Assay.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 27, 2026
Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center Cohort.
Journal: Asia-Pacific journal of clinical oncology
Published: August 21, 2025
Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.
Journal: JTO clinical and research reports
Published: August 15, 2025
Preoperative circulating tumor DNA detection and occult lymph node metastases in clinical stage I lung cancer: The lung DETECT study.
Journal: JTCVS open
Published: May 31, 2025
Impact of the COVID-19 Pandemic on Diagnosis and Multidisciplinary Treatment of NSCLC in Ontario, Canada.
Journal: JTO clinical and research reports
Published: April 10, 2025
Assessing the feasibility and external validity of natural language processing-extracted data for advanced lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 14, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center Experience.
Journal: Current oncology (Toronto, Ont.)
Published: June 04, 2024
Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence.
Journal: Current oncology (Toronto, Ont.)
Published: January 15, 2024
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.
Journal: JAMA network open
Published: July 25, 2023
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy.
Journal: Therapeutic advances in medical oncology
Published: June 24, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: May 14, 2022
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: April 05, 2022
Last Updated: 09/26/2026